This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

2020
Global Partnering Events,
Delivered Digitally

Three global partnering events. One low price. No travel required.

Make the important connections you need as you meet and partner with thousands of international dealmakers from the comfort of your home.

Make the important connections you need with a Virtual Passport


EBD Group is offering a Virtual Passport to attend all three of our remaining 2020 fully digital partnering conferences. Attendees from all sectors of life sciences can access the unparalleled partnering and content offered by ChinaBio® Partnering Forum, BioPharm America™ and BIO-Europe® with a Virtual Passport at a substantially reduced fee. Meet and partner with thousands of international dealmakers from the comfort of your home.

Turbocharge your partnering with Biomedtracker

Get 90-day complimentary access to Biomedtracker with your virtual passport.* Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries to help you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals.

*Some exclusions may apply.

Global Partnering Virtual Passport! Only $2,295

Your Virtual Passport includes:  

  • Registration and partneringONE® access to ChinaBio® Partnering Forum, BioPharm America™, BIO-Europe®
  • Access to select content (panels, keynotes, company presentations, exhibit showcase) from all three events
  • Exclusive access to premier content, reports, e-books and more
  • Complimentary 90-Day Access to Pharma Intelligence’s Biomedtracker 

YOUR VIRTUAL PASSPORT INCLUDES ENTRANCE TO THESE THREE PARTNERING EVENTS

Digital Experience: What to Expect at the Events!

  


ONE-TO-ONE MEETINGS
ONE-TO-ONE MEETINGS

Powered by parteneringONE®, all partnering meetings will be held through a secure video conferencing solution and will be scheduled over 24-hour timeframes to accommodate time zones across the world. 

Access to the partneringONE system is restricted to registered attendees.

Learn More
COMPANY PRESENTATIONS
COMPANY PRESENTATIONS

Presenting companies will have the opportunity to pre-record their presentation which will be available to all registered attendees a few weeks prior as well as throughout the duration of the event.

Learn more
KEYNOTES AND PANELS
KEYNOTES AND PANELS

Keynotes, panels and workshops will be held as video-supported webinars, available for all registered attendees throughout the duration of the event.

Learn more

Endless dealmaking opportunities during three digital partnering events!


EBD Group is excited to announce that our next three 2020 partnering conferences so valued by the biopharma community are being launched as fully digital events. 

While travel and face-to-face interaction may not be safe or even possible, biotech, pharma, and financial attendees can still access the unparalleled partnering and content offered by ChinaBio® Partnering Forum, BioPharm America™ and BIO-Europe® in August, September and October, either as individual conferences, or with a Virtual Passport to all three, at a substantially reduced fee. 

UNLOCK PREMIER CONTENT WITH YOUR VIRTUAL PASSPORT

Just Released! To access this exclusive content, sign up for your virtual passport and we'll send you the links.


BIOPHARMA AND TECH INNOVATORS
BIOPHARMA AND TECH INNOVATORS

The life science sector continues to strive towards innovation, the rapid progression of drugs, diagnostic tests, and healthcare tools. In this new e-book, Xconomy and EBD Group bring together the companies behind exciting innovations striving to change the healthcare world.

STATE OF CHINA LIFE SCIENCES 2020
STATE OF CHINA LIFE SCIENCES 2020

It is the golden era of healthcare in China due to robust government support, sweeping regulatory changes, and a strong talent base. This new report by ChinaBio gives an in-depth analysis of investment and partnering activity in China for 2019 and Q1 of 2020.

PHARMA R&D ANNUAL REVIEW 2020
PHARMA R&D ANNUAL REVIEW 2020

This whitepaper on pharma R&D uses a granular way of presenting and searching data that explicitly links each unique drug program’s developing company, disease, country, and status. It assesses industry trends by examining the pipelines of companies, therapeutic areas, diseases, targets, and drug types.